M&A - MASSMUTUAL SELECT FUNDS

Form Type: 497

Filing Date: 2025-03-24

Corporate Action: Merger

Type: New

Accession Number: 000110465925027315

Filing Summary: This document serves as a supplement to the Prospectuses dated February 1, 2025, detailing the upcoming reorganizations of the Selling Funds into corresponding Acquiring Funds. The Selling Funds include the MassMutual Total Return Bond Fund and the MassMutual Equity Opportunities Fund, which will be reorganized into the MassMutual Core Bond Fund and the MassMutual Diversified Value Fund, respectively. The reorganizations are anticipated to occur in September 2025 without requiring shareholder approval. Shareholders of the Selling Funds will receive shares of the Acquiring Funds equivalent in value to their current holdings, effectively liquidating the Selling Funds. The document notes that these reorganizations are expected to be tax-free under U.S. federal income tax regulations, though there is no guarantee they will proceed as planned. Shareholders may redeem their shares prior to the reorganizations, which could incur taxes. More comprehensive details on the Acquiring Funds and reorganizations will be available in a forthcoming combined information statement/prospectus.

Form Type: 497K

Filing Date: 2025-03-24

Corporate Action: Merger

Type: Update

Accession Number: 000110465925027318

Filing Summary: This document serves as a supplement to the Summary Prospectus dated February 1, 2025, for the MassMutual Diversified Value Fund. It outlines the approved reorganization of the MassMutual Equity Opportunities Fund into the MassMutual Diversified Value Fund, with the transaction anticipated to occur in September 2025, subject to certain conditions. Importantly, no shareholder approval is necessary for this reorganization. The selling fund's assets and liabilities will be transferred to the acquiring fund in exchange for shares of the acquiring fund, equivalent to the value of the selling fund's assets minus its liabilities. As a result, current shareholders of the selling fund will become shareholders of the acquiring fund without incurring a taxable event, ensuring a tax-free transaction for U.S. federal income tax purposes, provided all conditions are met. Shareholders retain the option to redeem shares of the selling fund prior to the reorganization; however, such transactions may be taxable. For further details regarding this merger, information statements, and prospectus will be provided once the registration statement is filed and effective.

Form Type: 497K

Filing Date: 2025-03-24

Corporate Action: Merger

Type: Update

Accession Number: 000110465925027319

Filing Summary: This document serves as a supplement to the Summary Prospectus for the MassMutual Equity Opportunities Fund, detailing the approved reorganization of the Selling Fund (MassMutual Equity Opportunities Fund) into the Acquiring Fund (MassMutual Diversified Value Fund). This reorganization is scheduled to take place in September 2025, pending the satisfaction of certain conditions, and does not require shareholder approval. Shareholders of the Selling Fund will be converted into shareholders of the Acquiring Fund on a pro-rata basis, receiving shares valued equivalently to their existing shares in the Selling Fund. Furthermore, this reorganization is expected to be tax-free for U.S. federal income tax purposes, although there is no guarantee that the transaction will occur. Shareholders are informed that they may redeem their shares before the reorganization, which could be subject to taxes.

Form Type: 497K

Filing Date: 2025-03-24

Corporate Action: Merger

Type: Update

Accession Number: 000110465925027322

Filing Summary: This document is a supplement to the Summary Prospectus of the MassMutual Total Return Bond Fund, providing new and additional information regarding its planned reorganization into the MassMutual Core Bond Fund, scheduled for September 2025. No shareholder approval is needed for this reorganization. The assets and liabilities of the Selling Fund will be transferred to the Acquiring Fund, resulting in shareholders of the Selling Fund receiving shares of the Acquiring Fund equal to the value of their previous holdings. The reorganization aims to be a tax-free event for U.S. federal income tax purposes, although there are no guarantees it will proceed as planned. Shareholders can redeem their shares at any time before the closing of the reorganization, which may lead to tax implications. More detailed information will be provided in a combined information statement/prospectus once filed with the SEC.